Clocking in on Diabetic Retinopathy

Diabetic retinopathy (DR) is the leading cause of blindness in the working-age population in the U.S. and has created a massive health care burden. Chronic hyperglycemia leads to specific changes in the retina, including the loss of pericytes, basement membrane thickening, and impaired endothelial cell function. However, the biological explanation of these cellular events remains unclear. Eventually, these changes lead to the formation of microaneurysms, the breakdown of the tight junctions in the retinal vasculature, subsequent extravasation of fluid, and vision loss. DR often progresses to a more deleterious proliferative phenotype due to profound ischemia with neovascularization of the retina and vitreous hemorrhage. Given this substantial clinical problem, many researchers are focused on resolving molecular mechanisms in DR pathogenesis to identify potential new therapeutic targets. Although a significant cache of data has amassed in studies linking DR to proinflammatory mediators such as vascular endothelial growth factor-A, oxidative stress, and abnormal glycosylation, there is growing excitement over the recent discovery linking circadian dysfunction and diabetes and the implications of this biology in the eye. The central mammalian clock located in the suprachiasmatic nucleus is sensitive to disturbances in the programmed 24-h circadian cycle controlled by the oscillatory expression of a clock gene cassette including Period (Per) 1–3, Cryptochrome (Cry) 1/2, Clock, and Bmal1/2. As the retina provides a critical signal entry point for both peripheral and central circadian clocks in mammals, this composite tissue provides an excellent platform to study potential interactions between circadian disruption and other cell types of vascular, neuronal, and immune origin. Specific nonvisual, light-sensing retinal ganglion cells harboring the photopigment melanopsin project axons to the suprachiasmatic nucleus, which then regulates the light cycle–dependent signal for circadian entrainment (1). Interestingly, the retina also runs its own internal clock to control photoreceptor turnover, dopaminergic responses, and visual sensitivity (2). In this issue, Bhatwadekar et al. (3) present new physiological and molecular insights into the circadian control of vascular regulation in the retina by Per2. This work not only offers insight into the contribution of Per2 to retinal vascular function and maintenance of the blood-retina barrier (BRB) but traverses into mechanisms of circadian control of bone marrow–derived progenitor cell (BMPC) release (Fig. 1). The precise functions of Per2 are minimally resolved, yet its expression is induced by the nuclear translocation of other master clock proteins, Bmal1/Clock, and it may contribute to a negative feedback loop to control the periodicity of circadian gene transcription (4). The Per2 gene contains a glucocorticoid-responsive element that is important in glucose homeostasis (5), and hyperglycemia downregulates expression of Per2 (6), giving the authors solid ground on which to base the current work. In a previous study, the authors clearly demonstrated the importance of diurnal rhythm and clock gene expression during BMPC release in a diabetic rat model (7). One of the most highly downregulated genes in BMPCs and retina in diabetic animals was Per2, suggesting that deficiency may be an important factor in DR pathogenesis. BMPC—specifically endothelial progenitor cell (EPC)—dysfunction correlates with diabetic disease severity and is hypothesized to decrease vascular repair capacity during disease progression (8). It is established that EPC release into the circulation in humans is under circadian control (9), and that disruption of Per2 leads to murine EPC dysfunction and senescence (10). The authors report in this issue that mice deficient in Per2 develop leaky retinal vasculature, acellular capillaries, and BMPC dysfunction, which recapitulate DR in both humans and other animal models. The key strengths of this article are expert histologic analysis of retinal morphology and immunofluorescence to identify diabetic-like disease features and the identification of key mechanisms that may lead to vascular compromise. The authors first study glucose homeostasis in Per2 mutant mice and observe normoglycemia and normal glucose tolerance tests. This is an important finding, as the authors were then able to dissect other potential diabetes-related mechanisms independent of hyperglycemia. The basal production of nitric oxide (NO) by endothelial NO synthase (eNOS) is critical for vascular homeostasis and maintenance of the BRB. Here, the authors observed decreased retinal eNOS protein and mRNA expression compared with wild-type animals and a later increase in inducible NOS (iNOS) at 12 months. Loss of basal eNOS expression and activation of iNOS results in overproduction of NO, leukostasis, and breakdown of the BRB in diabetic mice (11). Along with the high-quality trypsin digests demonstrating acellular capillaries in Per2-deficient retinas, these findings provide a glucose-independent mechanism through which the loss of circadian rhythm may induce significant retinal vascular permeability and derangements in highly organized retinal endothelial cell tight junctions. Another major strength in this article is the authors’ analyses of bone marrow dysfunction and BMPC release in Per2 mutant mice. They have previously shown bone marrow neuropathy and significantly decreased circulating BMPCs in a diabetic rat model (7), providing necessary evidence to support a system by which circadian control From the Department of Ophthalmology and Visual Sciences, University of Kentucky, Lexington, Kentucky; and the Department of Physiology, University of Kentucky, Lexington, Kentucky. Corresponding author: Jayakrishna Ambati, [email protected]. DOI: 10.2337/db12-1151 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details. See accompanying original article, p. 273.